SERPINA4
SERPINA4 (serpin family A member 4), also known as kallistatin, KST, KAL, KLST and PI4, is a secreted member of the serpin family of peptidase inhibitors. It inhibits the enzymatic activities of human tissue kallikrein. Browse Assay Genie's current range of SERPINA4 research reagents below, or read on for the biology behind the target.
SERPINA4, also called kallistatin, is a serpin that inhibits the amidolytic and kininogenase activities of human tissue kallikrein. Inhibition proceeds through formation of an equimolar complex between the inhibitor and the enzyme. This complex is stable to both heat and SDS. During complex formation, tissue kallikrein cleaves the inhibitor at its reactive site, which releases a small C-terminal fragment of SERPINA4.
The SERPINA4 gene encodes a secreted protein and belongs to the serpin family, which HGNC classes in the serpin peptidase inhibitors gene group. NCBI Gene describes the protein as predicted to enable serine-type endopeptidase inhibitor activity, and reports it in extracellular exosomes. Researchers studying the SERPINA4 gene or the SERPINA4 protein often examine it alongside other clade A serpins, which share the same overall fold and inhibitory mechanism.
The gene has gone by several names. Aliases and earlier symbols include KST, KAL, KLST and PI4, and older nomenclature refers to it as serine (or cysteine) proteinase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 4. NCBI Gene lists SERPINA4 as a biomarker of diabetic retinopathy, which makes it a point of interest for work on diabetic complications and on the regulation of kallikrein activity.
SERPINA4 inhibits tissue kallikrein by forming a stable complex with the enzyme, making it a model for serpin-protease interactions.
Cleavage at the reactive site releases a C-terminal fragment, a feature used to study how serpins trap their target proteases.
SERPINA4 is described as a biomarker of diabetic retinopathy, supporting its use in studies of this complication.
SERPINA4 is located in extracellular exosomes, which links it to research on secreted and vesicle-associated proteins.
SERPINA4, or kallistatin, inhibits the amidolytic and kininogenase activities of human tissue kallikrein. It forms an equimolar, heat- and SDS-stable complex with the enzyme, and cleavage at its reactive site generates a small C-terminal fragment of the inhibitor.
SERPINA4 is also known as kallistatin, KST, KAL, KLST and PI4. Earlier names describe it as serine (or cysteine) proteinase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 4. HGNC lists it in the serpin peptidase inhibitors group.
NCBI Gene describes SERPINA4 as a biomarker of diabetic retinopathy. It is also reported in extracellular exosomes. Beyond this, the supplied sources give no further disease associations, so check the primary literature for other links.
Other clade A serpins and related serine protease inhibitors with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt P29622; product specifications from Assay Genie datasheets.